Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases

作者：Mackey Rachel H^*; Kuller Lewis H; Moreland Larry W

来源：Rheumatic Disease Clinics of North America, 2018, 44(3): 475-+.

DOI：10.1016/j.rdc.2018.03.006

• Rheumatoid arthritis
• Cardiovascular
• Lipids
• Lipoproteins
• Myocardial fibrosis

Cardiovascular disease (CVD) risk is 1.5-fold higher in rheumatoid arthritis (RA), partly due to subclinical atherosclerosis that develops before the diagnosis of RA. Dyslipidemia in RA is better quantified by lipoproteins and apolipoproteins than by cholesterol levels. Current risk factors likely underestimate CVD risk by underestimating prior risk factor levels. Some of the 2-fold higher risk of heart failure and total mortality in RA may be due to myocardial disease caused by inflammation. Per recent recommendations, to reduce CVD risk in RA, control disease activity, reduce inflammation, and aggressively treat CVD risk factors.

• 出版日期2018-8